1
Total Mentions
1
Documents
0
Connected Entities
HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
83 2.83 14.2% Phase Forward Incorporated Convergence 1998 9.0 38.6 - 38.6 4.31 4.31 22.4% SGX, Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3% Skila, Inc. Convergence 1998 9.0 0.0 - 0.0 0.00 0.00 NM Spotfire, Inc. Convergence 1999 99 24.8 - 24.8 2.50 2.50 12.7% VascA, Inc. Healthcare Devices 1999 7 0.1 - 0.1 0.02 0
Page: HOUSE_OVERSIGHT_024104 →No connected entities